Morgan Stanley analyst Joseph Moore initiated coverage of Astera Labs with an Equal Weight rating and $81 price target. The analyst sees Astera as the highest growth company in the firm’s coverage, given its multiple products leveraged to the most important trends in compute. However, the stock is valued as such, which drives the neutral rating, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB: